Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

The aim of this study was to investigate the effects of soy isoflavones, vitamin D and their probable interactions in women with IBS.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Moreover, pregnant and lactating women were not recruited in the study.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Co-Administration of Soy Isoflavones and Vitamin D in Management of Irritable Bowel Disease

Study design awaiting verification · PLoS ONE · 2016

Original publication title

Co-Administration of Soy Isoflavones and Vitamin D in Management of Irritable Bowel Disease

Mahsa Jalili; Azita Hekmatdoost; Homayoon Vahedi; Hossein Poustchi; Behnam Khademi; Mohsen Saadi; Maryam Zemestani; Leila Janani

© 2016 Jalili et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Our results indicate that co-administration of soy isoflavones with vitamin D did not improve the IBS: SSS and IBS: QOL; however, it improved the IBS-TS.

An extract from the source publication. Read it in context.

At a glance

Abstract: Background and Aims

The substantial characteristics of Irritable Bowel Syndrome (IBS) are associated with estrogens in women. Both soy isoflavones and vitamin D can modulate estrogen receptors in the colonic smooth muscles. The aim of this study was to investigate the effects of soy isoflavones, vitamin D and their probable interactions in women with IBS.

Source: Background and Aims

Abstract: What methods does the paper describe?

In a factorial blinded randomized clinical trial, 100 women with IBS (age:18-75yr, were randomly assigned in 4 arms to receive either placebo of vitamin D and placebo of soy isoflavones (P+P), or placebo of vitamin D and soy isoflavones (P+S), or vitamin D and placebo of soy isoflavones (D+P), or vitamin D and soy isoflavones (D+S) for 6 weeks. Dosage of soy isoflavone was 2 capsules of 20 mg soy isoflavones per day, and dosage of vitamin D was one pearl of 50’000 IU biweekly.

The clinical outcomes were IBS symptoms severity scores (IBS-SSS), disease: specific quality of life (IBS-QOL) and total score (IBS-TS) that evaluated at weeks 0, 6, and 10, and compared to each other.

Source: Methods

Abstract: Results

IBS-TS improved significantly in both S+P and D+P groups (p: value = 0.004, 0.015). The interaction effect of soy isoflavones and vitamin D on IBS-TS was significant (p<0.05). The interaction effect of soy isoflavones with vitamin D and the main effect of vitamin D on IBS-SSS were not statistically significant, whereas IBS-SSS decreased significantly in S+P and D+P groups (p-value = 0.001, 0.047 respectively).

Source: Results

Abstract: Conclusion

Our results indicate that co-administration of soy isoflavones with vitamin D did not improve the IBS: SSS and IBS: QOL; however, it improved the IBS-TS.

Source: Conclusion
Authors’ abstract

Background and Aims

The substantial characteristics of Irritable Bowel Syndrome (IBS) are associated with estrogens in women. Both soy isoflavones and vitamin D can modulate estrogen receptors in the colonic smooth muscles. The aim of this study was to investigate the effects of soy isoflavones, vitamin D and their probable interactions in women with IBS.

Methods

In a factorial blinded randomized clinical trial, 100 women with IBS (age:18-75yr, were randomly assigned in 4 arms to receive either placebo of vitamin D and placebo of soy isoflavones (P+P), or placebo of vitamin D and soy isoflavones (P+S), or vitamin D and placebo of soy isoflavones (D+P), or vitamin D and soy isoflavones (D+S) for 6 weeks. Dosage of soy isoflavone was 2 capsules of 20 mg soy isoflavones per day, and dosage of vitamin D was one pearl of 50’000 IU biweekly.

The clinical outcomes were IBS symptoms severity scores (IBS-SSS), disease: specific quality of life (IBS-QOL) and total score (IBS-TS) that evaluated at weeks 0, 6, and 10, and compared to each other.

Results

IBS-TS improved significantly in both S+P and D+P groups (p: value = 0.004, 0.015). The interaction effect of soy isoflavones and vitamin D on IBS-TS was significant (p<0.05). The interaction effect of soy isoflavones with vitamin D and the main effect of vitamin D on IBS-SSS were not statistically significant, whereas IBS-SSS decreased significantly in S+P and D+P groups (p-value = 0.001, 0.047 respectively).

Conclusion

Our results indicate that co-administration of soy isoflavones with vitamin D did not improve the IBS: SSS and IBS: QOL; however, it improved the IBS-TS.

Trial Registration

Clinical Trials.gov NCT02026518

Publication and source details

Original title: Co-Administration of Soy Isoflavones and Vitamin D in Management of Irritable Bowel Disease

Mahsa Jalili; Azita Hekmatdoost; Homayoon Vahedi; Hossein Poustchi; Behnam Khademi; Mohsen Saadi; Maryam Zemestani; Leila Janani

PLoS ONE · 2016

Competing Interests: The authors have declared that no competing interests exist.

  • Conceived and designed the experiments: MJ AH LJ HV.

  • Analyzed the data: LJ MJ.

  • Wrote the paper: MJ AH LJ BK MS MZ.

  • Full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis: AH.

  • Critical revision of the manuscript for important intellectual content: AH, LJ, MJ, HP, HV.

  • Statistical analysis: LJ, MJ.

  • Obtained funding: AH, HP, HV.

  • Administrative, technical, or material support: AH, HP, HV, BK, MS, MZ.

  • Study supervision: AH, HV, HP.

* E-mail: leila_janani@yahoo.com (LJ); a_hekmat2000@yahoo.com (AH)
© 2016 Jalili et al2016Jalili et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.http://dx.doi.org/10.13039/501100005851Shahid Beheshti University of Medical Scienceshttp://orcid.org/0000-0001-7825-9483Jalili Mahsa http://dx.doi.org/10.13039/501100004484Tehran University of Medical Sciences and Health ServicesHekmatdoost Azita This work was supported by Hekmatdoost, Vahedi, Poustchi. Funding was granted from National Nutrition and Food Technology Research Institute, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T09:11:06.117200+00:00

DOI: 10.1371/journal.pone.0158545 · PMC4973900